Mounjaro (Tirzepatide) is an injectable medication that was initially approved for managing type 2 diabetes , but it has shown significant positive results for weight loss as well
Progress check-ins help keep you motivated, supported, and on track
Urgent situations requiring immediate medical attention include: Severe, persistent abdominal pain (with or without vomiting), which may indicate pancreatitis Signs of gallbladder disease (right upper quadrant pain, nausea) Persistent vomiting leading to inability to keep fluids down or signs of dehydration Specific situations requiring consultation include: Persistent gastrointestinal symptoms (nausea, vomiting, diarrhea) lasting beyond the initial adjustment period Unintended weight loss exceeding clinical targets or occurring too rapidly Signs of nutritional deficiency such as fatigue, weakness, hair loss, brittle nails, or neurological symptoms Difficulty meeting protein or caloric needs through diet alone Consideration of high-dose supplements or specialized nutritional products Use of multiple supplements or herbal products with potential interactions Need for medication adjustments if also taking insulin or sulfonylureas to prevent hypoglycemia Patients who are pregnant, planning pregnancy, or breastfeeding should discuss all medications and supplements with their healthcare provider, as certain products may be contraindicated
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, et al
Your doctor may adjust treatment to prevent low blood sugar and optimize results
Researchers are conducting a systematic review on dual agonists
